Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report

The "Vaccines and Related Biological Products Advisory Committee 17 December 2020 Meeting Briefing Document", formulated by the FDA, reported three cases of swelling in areas previously injected with HA filler, introducing the possible relationship between a COVID-19 vaccine and adverse ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied sciences 2021-11, Vol.11 (22), p.10888, Article 10888
Hauptverfasser: Rauso, Raffaele, Lo Giudice, Giorgio, Zerbinati, Nicola, Nicoletti, Giovanni Francesco, Fragola, Romolo, Tartaro, Gianpaolo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 22
container_start_page 10888
container_title Applied sciences
container_volume 11
creator Rauso, Raffaele
Lo Giudice, Giorgio
Zerbinati, Nicola
Nicoletti, Giovanni Francesco
Fragola, Romolo
Tartaro, Gianpaolo
description The "Vaccines and Related Biological Products Advisory Committee 17 December 2020 Meeting Briefing Document", formulated by the FDA, reported three cases of swelling in areas previously injected with HA filler, introducing the possible relationship between a COVID-19 vaccine and adverse events in areas previously injected with HA fillers. The aim of this research is to report a case of an adverse event following a COVID-19 vaccine in a patient previously injected with facial filler. Furthermore, a scoping review on the same topic was performed. The research was carried out on the electronic databases PubMed, Cochrane Library, Web of Science, Google Scholar and Scopus. The selection process identified four articles as eligible for inclusion in the review. Nineteen patients, including the described case report, who experienced an adverse event following a COVID-19 vaccine in areas previously injected with facial filler were identified. Adverse events following a COVID-19 vaccine in patients previously injected with facial filler appear to be rare. A high BDDE cross-linking rate and/or a low-molecular-weight hyaluronic acid filler may have a higher tardive adverse event rate when triggered.
doi_str_mv 10.3390/app112210888
format Article
fullrecord <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_000778205300041CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4ce193a4fd904da1952162e2e0972afe</doaj_id><sourcerecordid>2602013005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-1d274afc82bad190ca66b6f3abec236a1cb2bdad06ceaaaa13c26430740b87c33</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhSMEElXpjR9giSOkeOzUSbhVoQsrVWpVoFdrYk-KV8EOtndXlfjxuF1U9chcZmR97401r6reAj-VsucfcVkAhADedd2L6kjwVtWygfbls_l1dZLShpfqQXbAj6o_53ZHMRG72JHPia3CPIe983dsuLpdf66hZ7dojPPEnGfXmN0jdh1p58I2zfds7TdkMlm2d_knW6FxOLOVm2eKn9g3E5YHs5uC056ht2zAsu2GlhDzm-rVhHOik3_9uPqxuvg-fK0vr76sh_PL2kjV5hqsaBucTCdGtNBzg0qNapI4khFSIZhRjBYtV4awFEgjVCN52_Cxa42Ux9X64GsDbvQS3S-M9zqg048PId5pjNmZmXRjCHqJzWR73liE_kyAEiSI963AiYrXu4PXEsPvLaWsN2Ebffm-FooLDpLzs0J9OFAmhpQiTU9bgeuHuPTzuAreHfA9jWFKphzZ0JOkxNW2nSi2ZWpgcLnEEPwQtj4X6fv_l8q_tIOoYQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2602013005</pqid></control><display><type>article</type><title>Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><creator>Rauso, Raffaele ; Lo Giudice, Giorgio ; Zerbinati, Nicola ; Nicoletti, Giovanni Francesco ; Fragola, Romolo ; Tartaro, Gianpaolo</creator><creatorcontrib>Rauso, Raffaele ; Lo Giudice, Giorgio ; Zerbinati, Nicola ; Nicoletti, Giovanni Francesco ; Fragola, Romolo ; Tartaro, Gianpaolo</creatorcontrib><description>The "Vaccines and Related Biological Products Advisory Committee 17 December 2020 Meeting Briefing Document", formulated by the FDA, reported three cases of swelling in areas previously injected with HA filler, introducing the possible relationship between a COVID-19 vaccine and adverse events in areas previously injected with HA fillers. The aim of this research is to report a case of an adverse event following a COVID-19 vaccine in a patient previously injected with facial filler. Furthermore, a scoping review on the same topic was performed. The research was carried out on the electronic databases PubMed, Cochrane Library, Web of Science, Google Scholar and Scopus. The selection process identified four articles as eligible for inclusion in the review. Nineteen patients, including the described case report, who experienced an adverse event following a COVID-19 vaccine in areas previously injected with facial filler were identified. Adverse events following a COVID-19 vaccine in patients previously injected with facial filler appear to be rare. A high BDDE cross-linking rate and/or a low-molecular-weight hyaluronic acid filler may have a higher tardive adverse event rate when triggered.</description><identifier>ISSN: 2076-3417</identifier><identifier>EISSN: 2076-3417</identifier><identifier>DOI: 10.3390/app112210888</identifier><language>eng</language><publisher>BASEL: Mdpi</publisher><subject>adverse reaction ; Case reports ; Chemistry ; Chemistry, Multidisciplinary ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Crosslinking ; Dermal fillers ; Edema ; Engineering ; Engineering, Multidisciplinary ; filler ; Fillers ; Hyaluronic acid ; Injections ; Materials Science ; Materials Science, Multidisciplinary ; Pandemics ; Patients ; Physical Sciences ; Physics ; Physics, Applied ; SARS-CoV-2 ; Science &amp; Technology ; Technology ; Vaccines</subject><ispartof>Applied sciences, 2021-11, Vol.11 (22), p.10888, Article 10888</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000778205300041</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c367t-1d274afc82bad190ca66b6f3abec236a1cb2bdad06ceaaaa13c26430740b87c33</citedby><cites>FETCH-LOGICAL-c367t-1d274afc82bad190ca66b6f3abec236a1cb2bdad06ceaaaa13c26430740b87c33</cites><orcidid>0000-0002-8289-5527 ; 0000-0002-4497-3563 ; 0000-0001-9944-1073</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,866,2104,2116,27931,27932,39265</link.rule.ids></links><search><creatorcontrib>Rauso, Raffaele</creatorcontrib><creatorcontrib>Lo Giudice, Giorgio</creatorcontrib><creatorcontrib>Zerbinati, Nicola</creatorcontrib><creatorcontrib>Nicoletti, Giovanni Francesco</creatorcontrib><creatorcontrib>Fragola, Romolo</creatorcontrib><creatorcontrib>Tartaro, Gianpaolo</creatorcontrib><title>Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report</title><title>Applied sciences</title><addtitle>APPL SCI-BASEL</addtitle><description>The "Vaccines and Related Biological Products Advisory Committee 17 December 2020 Meeting Briefing Document", formulated by the FDA, reported three cases of swelling in areas previously injected with HA filler, introducing the possible relationship between a COVID-19 vaccine and adverse events in areas previously injected with HA fillers. The aim of this research is to report a case of an adverse event following a COVID-19 vaccine in a patient previously injected with facial filler. Furthermore, a scoping review on the same topic was performed. The research was carried out on the electronic databases PubMed, Cochrane Library, Web of Science, Google Scholar and Scopus. The selection process identified four articles as eligible for inclusion in the review. Nineteen patients, including the described case report, who experienced an adverse event following a COVID-19 vaccine in areas previously injected with facial filler were identified. Adverse events following a COVID-19 vaccine in patients previously injected with facial filler appear to be rare. A high BDDE cross-linking rate and/or a low-molecular-weight hyaluronic acid filler may have a higher tardive adverse event rate when triggered.</description><subject>adverse reaction</subject><subject>Case reports</subject><subject>Chemistry</subject><subject>Chemistry, Multidisciplinary</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Crosslinking</subject><subject>Dermal fillers</subject><subject>Edema</subject><subject>Engineering</subject><subject>Engineering, Multidisciplinary</subject><subject>filler</subject><subject>Fillers</subject><subject>Hyaluronic acid</subject><subject>Injections</subject><subject>Materials Science</subject><subject>Materials Science, Multidisciplinary</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Physics</subject><subject>Physics, Applied</subject><subject>SARS-CoV-2</subject><subject>Science &amp; Technology</subject><subject>Technology</subject><subject>Vaccines</subject><issn>2076-3417</issn><issn>2076-3417</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNqNkUFv1DAQhSMEElXpjR9giSOkeOzUSbhVoQsrVWpVoFdrYk-KV8EOtndXlfjxuF1U9chcZmR97401r6reAj-VsucfcVkAhADedd2L6kjwVtWygfbls_l1dZLShpfqQXbAj6o_53ZHMRG72JHPia3CPIe983dsuLpdf66hZ7dojPPEnGfXmN0jdh1p58I2zfds7TdkMlm2d_knW6FxOLOVm2eKn9g3E5YHs5uC056ht2zAsu2GlhDzm-rVhHOik3_9uPqxuvg-fK0vr76sh_PL2kjV5hqsaBucTCdGtNBzg0qNapI4khFSIZhRjBYtV4awFEgjVCN52_Cxa42Ux9X64GsDbvQS3S-M9zqg048PId5pjNmZmXRjCHqJzWR73liE_kyAEiSI963AiYrXu4PXEsPvLaWsN2Ebffm-FooLDpLzs0J9OFAmhpQiTU9bgeuHuPTzuAreHfA9jWFKphzZ0JOkxNW2nSi2ZWpgcLnEEPwQtj4X6fv_l8q_tIOoYQ</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Rauso, Raffaele</creator><creator>Lo Giudice, Giorgio</creator><creator>Zerbinati, Nicola</creator><creator>Nicoletti, Giovanni Francesco</creator><creator>Fragola, Romolo</creator><creator>Tartaro, Gianpaolo</creator><general>Mdpi</general><general>MDPI AG</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8289-5527</orcidid><orcidid>https://orcid.org/0000-0002-4497-3563</orcidid><orcidid>https://orcid.org/0000-0001-9944-1073</orcidid></search><sort><creationdate>20211101</creationdate><title>Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report</title><author>Rauso, Raffaele ; Lo Giudice, Giorgio ; Zerbinati, Nicola ; Nicoletti, Giovanni Francesco ; Fragola, Romolo ; Tartaro, Gianpaolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-1d274afc82bad190ca66b6f3abec236a1cb2bdad06ceaaaa13c26430740b87c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adverse reaction</topic><topic>Case reports</topic><topic>Chemistry</topic><topic>Chemistry, Multidisciplinary</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Crosslinking</topic><topic>Dermal fillers</topic><topic>Edema</topic><topic>Engineering</topic><topic>Engineering, Multidisciplinary</topic><topic>filler</topic><topic>Fillers</topic><topic>Hyaluronic acid</topic><topic>Injections</topic><topic>Materials Science</topic><topic>Materials Science, Multidisciplinary</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Physics</topic><topic>Physics, Applied</topic><topic>SARS-CoV-2</topic><topic>Science &amp; Technology</topic><topic>Technology</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rauso, Raffaele</creatorcontrib><creatorcontrib>Lo Giudice, Giorgio</creatorcontrib><creatorcontrib>Zerbinati, Nicola</creatorcontrib><creatorcontrib>Nicoletti, Giovanni Francesco</creatorcontrib><creatorcontrib>Fragola, Romolo</creatorcontrib><creatorcontrib>Tartaro, Gianpaolo</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Applied sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rauso, Raffaele</au><au>Lo Giudice, Giorgio</au><au>Zerbinati, Nicola</au><au>Nicoletti, Giovanni Francesco</au><au>Fragola, Romolo</au><au>Tartaro, Gianpaolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report</atitle><jtitle>Applied sciences</jtitle><stitle>APPL SCI-BASEL</stitle><date>2021-11-01</date><risdate>2021</risdate><volume>11</volume><issue>22</issue><spage>10888</spage><pages>10888-</pages><artnum>10888</artnum><issn>2076-3417</issn><eissn>2076-3417</eissn><abstract>The "Vaccines and Related Biological Products Advisory Committee 17 December 2020 Meeting Briefing Document", formulated by the FDA, reported three cases of swelling in areas previously injected with HA filler, introducing the possible relationship between a COVID-19 vaccine and adverse events in areas previously injected with HA fillers. The aim of this research is to report a case of an adverse event following a COVID-19 vaccine in a patient previously injected with facial filler. Furthermore, a scoping review on the same topic was performed. The research was carried out on the electronic databases PubMed, Cochrane Library, Web of Science, Google Scholar and Scopus. The selection process identified four articles as eligible for inclusion in the review. Nineteen patients, including the described case report, who experienced an adverse event following a COVID-19 vaccine in areas previously injected with facial filler were identified. Adverse events following a COVID-19 vaccine in patients previously injected with facial filler appear to be rare. A high BDDE cross-linking rate and/or a low-molecular-weight hyaluronic acid filler may have a higher tardive adverse event rate when triggered.</abstract><cop>BASEL</cop><pub>Mdpi</pub><doi>10.3390/app112210888</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-8289-5527</orcidid><orcidid>https://orcid.org/0000-0002-4497-3563</orcidid><orcidid>https://orcid.org/0000-0001-9944-1073</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2076-3417
ispartof Applied sciences, 2021-11, Vol.11 (22), p.10888, Article 10888
issn 2076-3417
2076-3417
language eng
recordid cdi_webofscience_primary_000778205300041CitationCount
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />
subjects adverse reaction
Case reports
Chemistry
Chemistry, Multidisciplinary
Coronaviruses
COVID-19
COVID-19 vaccines
Crosslinking
Dermal fillers
Edema
Engineering
Engineering, Multidisciplinary
filler
Fillers
Hyaluronic acid
Injections
Materials Science
Materials Science, Multidisciplinary
Pandemics
Patients
Physical Sciences
Physics
Physics, Applied
SARS-CoV-2
Science & Technology
Technology
Vaccines
title Adverse Events Following COVID-19 Vaccine in Patients Previously Injected with Facial Filler: Scoping Review and Case Report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-06T01%3A16%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adverse%20Events%20Following%20COVID-19%20Vaccine%20in%20Patients%20Previously%20Injected%20with%20Facial%20Filler:%20Scoping%20Review%20and%20Case%20Report&rft.jtitle=Applied%20sciences&rft.au=Rauso,%20Raffaele&rft.date=2021-11-01&rft.volume=11&rft.issue=22&rft.spage=10888&rft.pages=10888-&rft.artnum=10888&rft.issn=2076-3417&rft.eissn=2076-3417&rft_id=info:doi/10.3390/app112210888&rft_dat=%3Cproquest_webof%3E2602013005%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2602013005&rft_id=info:pmid/&rft_doaj_id=oai_doaj_org_article_4ce193a4fd904da1952162e2e0972afe&rfr_iscdi=true